Man dies of asthma attack after inhaler cost skyrockets to more than $500
Cole Schmidtknecht expected to pay $66.86 for a three-month supply of his preventative asthma inhalers in January 2024 when he went to his Walgreens pharmacy in Appleton, Wisconsin. The pharmacy allegedly told him his insurance no longer covered the medication, so he would have to pay the full cost.
The bill: $539.19, according to a recently filed lawsuit.
Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post.
Schmidtknecht, 22, couldn't afford that, and so for the next five days, he struggled to breathe with only an emergency asthma inhaler, the suit states.
Then, on Jan. 15, he had a severe asthma attack. Within minutes, he was brain-dead. Six days later, his parents took him off life support.
Now, Bil and Shanon Schmidtknecht, both 47, are filing a wrongful death and negligence lawsuit against the pharmacy and pharmacy benefit manager that had been supplying their son with his asthma medication.
In a 26-page complaint filed on Jan. 21 in the U.S. District Court for Eastern Wisconsin, the Schmidtknechts accuse Optum Rx - a subsidiary of United Health Group and one of the country's three largest pharmacy benefit managers - of illegally denying Cole his 'life-saving' inhaler, forcing him to unexpectedly bear the full cost of the medication, the Schmidtknechts' lawyer, Michael Trunk, said. They allege that the Walgreens pharmacy in Appleton failed to inform him or his doctor of alternative medications.
'We want to get justice for our son,' Bil told The Washington Post, 'and want to make sure it does not happen to someone else.'
Optum Rx declined to comment on the lawsuit, but in April, the company told the Madison, Wisconsin-based TV station WMSN that it instructed the Walgreens pharmacy in Appleton to tell Cole to contact the doctor who prescribed Advair Diskus about getting three 'clinically-appropriate' alternatives that were covered.
The pharmacy never did, the Schmidtknechts allege.
Walgreens spokesman Marty Maloney said the company was declining to comment on the Schmidtknechts' lawsuit.
---
Failure to advise
Barry Furrow, law professor and director of Drexel University's health law program, said the strongest part of the Schmidtknechts' lawsuit is the allegation that the pharmacy failed to tell their son about alternatives to Advair. Furrow cited the Omnibus Budget Reconciliation Act of 1990, a law which expanded pharmacists' power and increased their responsibility to act on medical errors and conflicting prescriptions that came in.
'It seems to me there was a failure here to advise,' Furrow said. But, he added, Walgreens will almost certainly blame Cole for not being more proactive about asking the pharmacy about alternatives to Advair.
Furrow called the Schmidtknechts' claim against Optum Rx 'a bit of stretch' if Optum, as it claims, directed the pharmacy to tell Cole to contact his doctor about alternative medications. But, he added, the Schmidtknechts will be highly sympathetic plaintiffs if their case against Optum makes it in front of jurors, who, given a spate of bad news coverage against PBMs, could be inclined to punish 'the biggest bad actor here.'
Jurors 'are just going to kill them,' said Furrow, who works at Drexel's law school, which is named after Thomas Kline, a founding partner of Kline and Specter, the law firm representing the Schmidtknechts.
---
'Pretty life-changing'
Cole Schmidtknecht had struggled with chronic asthma since he was a toddler, his parents said. As soon as he could run, he was dogged by high-pitched wheezing. That came as no surprise to his parents who are lifelong asthmatics and suspected they might pass on the malady to their child.
In early childhood, Schmidtknecht's asthma meant being tethered to an albuterol emergency inhaler and unexpected trips to the emergency room, according to the Schmidtknechts. Meanwhile, he developed a love of sports, especially flag football and then Pop Warner, which meant coping with his illness.
When he was about 13, he started taking Advair Diskus, a preventative corticosteroid inhaler, they said. Each morning, he would take a hit and rarely need to worry about having trouble breathing, whether he was walking around, playing with his younger brother or bull-rushing a quarterback on the football field.
'It was pretty life-changing,' Shanon Schmidtknecht said, adding: 'He was just a normal, active kid.'
Advair became an unthinking part of Cole Schmidtknecht's daily routine for the next decade, his parents said. Once he started working in parts sales for a trucking company in March 2023 and got medical coverage as a result, he went to the pharmacy every three months to pay $67 for three 30-day Advair inhalers, Trunk, wrote in the lawsuit.
He expected to do the same on Jan. 10, 2024, but didn't know that Optum Rx had stopped covering Advair in the new year, according to the suit. The Walgreens pharmacy allegedly told him he would have to pay full price, which was more than eight times his normal co-pay.
Schmidtknecht, who made what his parents described as a 'modest hourly wage,' left without it and, unbeknownst to his parents, struggled to breathe over the next five days while relying on his emergency albuterol inhaler, the suit states.
On Jan. 15, Schmidtknecht had a severe asthma attack and started to asphyxiate, according to the suit. His roommate started driving him to ThedaCare Regional Medical Center-Appleton hospital about a six-minute ride from their duplex, his parents said. During the trip, Schmidtknecht passed out about two minutes before they got there, and by the time they'd arrived, Cole was blue and didn't have a pulse, the suit states.
Medical staff gave him two doses of epinephrine and performed two rounds of cardiopulmonary resuscitation lasting four minutes, according to the suit. An emergency room doctor called the Schmidtknechts, who made the roughly 100-mile trip to the hospital, they said in an interview. The doctor told them they had their son on life support and were monitoring his brain activity, they said. The next two to three days would be critical as they took Cole off sedatives and got a better sense of how long his brain had been deprived of oxygen, he told them.
When doctors did, there was little to no brain activity, the Schmidtknechts said. Flanked by nurses, a neurologist broke the bad news to his parents: Their son was in a vegetative state and would never wake up, the Schmidtknechts said. Anticipating his parents' reaction, nurses shoved chairs under them to stop them from crashing to the floor. Shanon fell into one while Bil collapsed onto Cole's chest.
As the doctor and nurses left the room, they both cried in silence at his bedside.
In the coming days, they got to say goodbye. So did others. Family friends and co-workers cycled into his hospital room in 20-minute blocks to talk to him one last time and offer his parents condolences. Meanwhile, doctors from around the country scrambled to Appleton to quickly harvest some of his body - bone, tissue and his eyes - so he could help others.
On Jan. 21, as doctors took Cole off life support, Shanon ducked out of his hospital room, unable to bear the sound of her son's death rattle, she said. Bil remained, and in Cole's final moments, he put his head on his first born's chest.
He heard his heart stop.
---
'So preventable'
In the weeks and months after Schmidtknecht's death, his parents learned he had tried and failed to get his Advair prescription because of the $540 price tag but didn't know why the cost had skyrocketed. They wondered if he had forgotten his insurance card.
About two weeks after Schmidtknecht's asthma attack, Shanon said, she tried to fill her husband's Advair prescription at their local independent pharmacy only to learn the reason for the price increase: Optum Rx no longer covered it, she said. The difference: Their pharmacist took the time to tell Shanon about possible workarounds, they said. Bil got an alternative inhaler.
Like his son, Bil had received no notice from Optum about the company no longer covering Advair in the new year, he said. Wisconsin law requires pharmacy benefit managers to notify patients when they stop covering or raise the prices on prescriptions to give them time to ask for an exemption, the suit states. The law also lets pharmacists substitute a brand prescription with a generic equivalent without approval from the prescribing doctor.
The Schmidtknechts said that, as they dug into how PBMs operate, they learned about their practice of taking 'kickbacks' from pharmaceutical companies, which, according to their lawsuit, pay what are 'euphemistically called 'rebates' and/or 'compensation.'' In exchange, PBMs push the drug manufacturers medications while excluding their competitors' drugs and their generic equivalents, even if they're better.
Heartbreak transformed into outrage.
'It was so preventable,' Shanon said of her son's death.
---
'I have his voice'
Bil Schmidtknecht quit his job at the trucking company last month on Jan. 17 and on Jan. 21, the anniversary of his son's death, began working at a relatively small pharmacy benefit manager in a position dedicated to making sure the company treats its customers well. He started pushing for state and federal legislation to reform how pharmacy benefit managers operate in the health care industry. He said he's working with the Wisconsin senate president, state and national pharmacy associations, the Federal Trade Commission and the U.S. Department of Justice.
He's specifically asking lawmakers to stop pharmacy benefit managers from engaging in 'mafia-like tactics' like under-reimbursing local pharmacies, which are rapidly shutting down around the country, further increasing PBMs' power in the marketplace.
Schmidtknecht also wants PBMs banned from taking what he called 'kickbacks' to deny patients' the best medication to treat their conditions.
'That's got to stop,' he said, adding that he realizes he's in a special position to effect change, which he plans to use.
'I have a story of a tragic story of my son, and I have his voice,' he said. But there are a lot of other parents in similar situations who don't have the time or the energy to fight.
'I'm doing it for everybody, and we're going to continue to push until we get something meaningful done, that it's going to make sure that people can get their medicine.'
Related Content
My mom died in 2020. I just found 86 unheard voicemails from her on my phone.
In Idaho, a preview of RFK Jr.'s vaccine-skeptical America
Circles of life
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
WEAVE LIVING and KKR Build on Strategic Partnership with Acquisition of Portfolio of Residential Properties in Prime Central Tokyo
Over 240 new units in upscale Tokyo locations set to open from Autumn 2025 TOKYO, June 10, 2025--(BUSINESS WIRE)--WEAVE LIVING, Asia-Pacific's pre-eminent living sector specialist, and KKR, a leading global investment firm, today announced the signing of definitive agreements to acquire six properties in prime Tokyo locations. The move builds on the continued momentum of the Weave Living Japan Residential Venture I ("WLJRV I") strategic partnership between WEAVE LIVING and KKR. With the latest acquisitions, the strategic partnership has grown its portfolio to 17 properties within the first six months of its establishment. Three of these new acquisitions are located in Tokyo's upscale Minato ward neighbourhoods of Roppongi, Minami Azabu and Shirokane. WEAVE LIVING will also introduce its premium WEAVE RESIDENCES brand as part of its Roppongi and Minami Azabu offerings, featuring luxurious, metropolitan living in spacious, fully furnished family-friendly homes, complete with modern decor, and thoughtful design finishes. These homes will help meet growing demand by discerning executives seeking an elevated living experience in the supply-constrained Minato area. The remaining locations will expand the WEAVE PLACE brand, offering beautifully designed private apartments with various furnished options catering to the respective needs of a diverse tenant base including local professionals, expatriates and corporates. Under these plans, more than 240 fully-furnished luxury rental properties are expected to be ready starting from fall 2025. "As part of our steady growth in the Japan market and across Asia-Pacific, we are thrilled to expand our collaboration with KKR and our Japan-based offering to six new locations that are extremely desirable even by Tokyo standards," said Sachin Doshi, Founder and Group CEO of WEAVE LIVING. "Also factoring in the planned Japan debut of our WEAVE RESIDENCES brand, this is a further demonstration of our commitment to offering an ever-wider selection of living options to renters at various life stages, with an emphasis on the distinctive attractiveness of each of the fantastic locations that make up our expanded portfolio in Tokyo." Kensuke Kudo, Managing Director, Real Estate, KKR, said, "We are proud of the strong momentum that our strategic partnership with WEAVE LIVING has achieved in a short span of time. This expansion underscores our conviction in the long-term fundamentals of Japan's residential sector and ability to deliver high-quality, differentiated offerings to meet the evolving residential needs of corporates and executives in Japan. We look forward to continued collaboration with Sachin to scale this promising platform." KKR is making its investment from its Asia real estate strategy. The transaction adds to KKR's continued activity and momentum in Japan's real estate sector across different real estate investment strategies, including KJR Management, a leading Japanese real estate manager that oversees two J-REITs; hospitality and office assets across Japan; and a portfolio of multifamily properties in Tokyo. A full overview of WEAVE LIVING's existing Tokyo locations can be found on the recently revamped WEAVE LIVING website, along with details on a unique rental offering that includes flexible lease periods; transparent payment plans inclusive of all Wi-Fi and utilities; a fully digital-first leasing experience; tenant support via the proprietary WEAVE LIVING mobile app; and a welcome respite from prohibitive up-front charges typical in the Japanese multi-family rental market. Leasing enquiriesTel: (+81) 03-6262-5628Email: Existing locations: Weave Place – Shinkamata, Weave Place – Kanda East, Weave Place – Asakusa South, Weave Place – Asakusa Kaminarimon, Weave Place – Ueno South, Weave Place – Waseda Park, Weave Place – Higashi-Koenji, Weave Place – Monzennakacho, Weave Place – Morishita, Weave Place – Ryogoku, Weave Place – Kunitachi For full details of property lineup and available units, and to request viewings, please visit About WEAVE LIVINGWeave Living is a leading provider of urban rental accommodation in key gateway cities throughout Asia Pacific. Since its founding in 2017 by Sachin Doshi, Weave has reimagined renting a home in big cities so more people can live their best life, wherever they are on their adventure. Weave currently offers four unique living options that cater to a diverse range of modern lifestyles: luxurious Weave Residences; fully serviced Weave Suites; self-contained Weave Place; and social co-living Weave Studios. Each class-leading home combines modern aesthetics, superior finishes, and a fully tech-enabled experience together with superior comfort and flexibility in the best urban locations. At present, Weave owns and manages residential properties in Hong Kong, Singapore, Japan, and South Korea, with more on the way. Weave LivingWebsite: Instagram: @liveatweave Facebook: @liveatweave About KKRKKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR's insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR's investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR's website at For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group's website at View source version on Contacts Media Enquiries This press release is disseminated by Kyodo PR on behalf of Weave Living. For more information or for interview opportunities, please contact: David McMahon (English)Email: Tel: (+81) 080-8914-9376 Aya Asoshina (Japanese)Email: a-asoshina@ Tel: (+81) 070-4303-7299 For KKR: Wei Jun Ong+65 6922 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Business Wire
32 minutes ago
- Business Wire
WEAVE LIVING and KKR Build on Strategic Partnership with Acquisition of Portfolio of Residential Properties in Prime Central Tokyo
TOKYO--(BUSINESS WIRE)--WEAVE LIVING, Asia-Pacific's pre-eminent living sector specialist, and KKR, a leading global investment firm, today announced the signing of definitive agreements to acquire six properties in prime Tokyo locations. The move builds on the continued momentum of the Weave Living Japan Residential Venture I ('WLJRV I') strategic partnership between WEAVE LIVING and KKR. With the latest acquisitions, the strategic partnership has grown its portfolio to 17 properties within the first six months of its establishment. Three of these new acquisitions are located in Tokyo's upscale Minato ward neighbourhoods of Roppongi, Minami Azabu and Shirokane. WEAVE LIVING will also introduce its premium WEAVE RESIDENCES brand as part of its Roppongi and Minami Azabu offerings, featuring luxurious, metropolitan living in spacious, fully furnished family-friendly homes, complete with modern decor, and thoughtful design finishes. These homes will help meet growing demand by discerning executives seeking an elevated living experience in the supply-constrained Minato area. The remaining locations will expand the WEAVE PLACE brand, offering beautifully designed private apartments with various furnished options catering to the respective needs of a diverse tenant base including local professionals, expatriates and corporates. Under these plans, more than 240 fully-furnished luxury rental properties are expected to be ready starting from fall 2025. 'As part of our steady growth in the Japan market and across Asia-Pacific, we are thrilled to expand our collaboration with KKR and our Japan-based offering to six new locations that are extremely desirable even by Tokyo standards,' said Sachin Doshi, Founder and Group CEO of WEAVE LIVING. 'Also factoring in the planned Japan debut of our WEAVE RESIDENCES brand, this is a further demonstration of our commitment to offering an ever-wider selection of living options to renters at various life stages, with an emphasis on the distinctive attractiveness of each of the fantastic locations that make up our expanded portfolio in Tokyo.' Kensuke Kudo, Managing Director, Real Estate, KKR, said, 'We are proud of the strong momentum that our strategic partnership with WEAVE LIVING has achieved in a short span of time. This expansion underscores our conviction in the long-term fundamentals of Japan's residential sector and ability to deliver high-quality, differentiated offerings to meet the evolving residential needs of corporates and executives in Japan. We look forward to continued collaboration with Sachin to scale this promising platform.' KKR is making its investment from its Asia real estate strategy. The transaction adds to KKR's continued activity and momentum in Japan's real estate sector across different real estate investment strategies, including KJR Management, a leading Japanese real estate manager that oversees two J-REITs; hospitality and office assets across Japan; and a portfolio of multifamily properties in Tokyo. A full overview of WEAVE LIVING's existing Tokyo locations can be found on the recently revamped WEAVE LIVING website, along with details on a unique rental offering that includes flexible lease periods; transparent payment plans inclusive of all Wi-Fi and utilities; a fully digital-first leasing experience; tenant support via the proprietary WEAVE LIVING mobile app; and a welcome respite from prohibitive up-front charges typical in the Japanese multi-family rental market. Existing locations: Weave Place – Shinkamata, Weave Place – Kanda East, Weave Place – Asakusa South, Weave Place – Asakusa Kaminarimon, Weave Place – Ueno South, Weave Place – Waseda Park, Weave Place – Higashi-Koenji, Weave Place – Monzennakacho, Weave Place – Morishita, Weave Place – Ryogoku, Weave Place – Kunitachi For full details of property lineup and available units, and to request viewings, please visit About WEAVE LIVING Weave Living is a leading provider of urban rental accommodation in key gateway cities throughout Asia Pacific. Since its founding in 2017 by Sachin Doshi, Weave has reimagined renting a home in big cities so more people can live their best life, wherever they are on their adventure. Weave currently offers four unique living options that cater to a diverse range of modern lifestyles: luxurious Weave Residences; fully serviced Weave Suites; self-contained Weave Place; and social co-living Weave Studios. Each class-leading home combines modern aesthetics, superior finishes, and a fully tech-enabled experience together with superior comfort and flexibility in the best urban locations. At present, Weave owns and manages residential properties in Hong Kong, Singapore, Japan, and South Korea, with more on the way. About KKR KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR's insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR's investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR's website at For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group's website at


Business Upturn
44 minutes ago
- Business Upturn
MemoDefend Announces Official Website Update Featuring Natural Daily Supplement for Cognitive Support
Lakeland, June 09, 2025 (GLOBE NEWSWIRE) — MemoDefend, a Florida-based wellness brand, has updated its official website to provide consumers with new information about its daily supplement formulated to support cognitive clarity and brain function in adults. Now available nationwide, the natural memory support formula is designed for individuals seeking a consistent, easy-to-integrate wellness solution. According to the official product website ( MemoDefend is intended to work in harmony with the body's internal processes to support healthy memory retention, mental sharpness, and overall cognitive performance. The brand highlights its approach as one that simplifies brain wellness without requiring restrictive regimens or complicated routines. 'We developed MemoDefend to help adults support brain health naturally—without disrupting their lifestyle,' said a company spokesperson. 'This product reflects our focus on purity, simplicity, and long-term wellness.' The company states that MemoDefend is produced in facilities that follow strict quality control practices. Its formulation features a selection of ingredients that align with adult wellness priorities such as cognitive support, mental clarity, and healthy aging. As noted on the website, MemoDefend includes a satisfaction guarantee for new customers. Those interested in learning more about its intended use or placing an order can find full details, customer support access, and purchasing options directly at the official website. About MemoDefend MemoDefend is a Lakeland, Florida-based wellness brand committed to delivering natural, easy-to-use supplements that support everyday health routines. Focused on transparency and simplicity, the company develops formulas to help adults feel more confident in their wellness journey—one daily step at a time. Product and Contact Information Brand: MemoDefend Website: Email: [email protected] Phone: +1 (888) 535-1590 Mailing Address: P.O. Box 90129, Lakeland, FL 33804, United States Disclaimer This release is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. The statements made about this product have not been evaluated by the Food and Drug Administration. Individual results may vary. Consumers should consult a qualified healthcare provider before beginning any new dietary supplement. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.